Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10443)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
SETDB1
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Responsed Disease | Pulmonary fibrosis | ICD-11: CB03 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell adhesion molecules | hsa04514 | ||||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
A-549 cells | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
In Vivo Model |
Forty Sprague-Dawley rats (weight 200 ± 20 g) were obtained from the Experimental Animal Center of Henan Province. The pulmonary fibrosis rat model was established using previously described techniques. The rats were administered a tracheal infusion of bleomycin at a concentration of 5 mg/kg in sterile 0.9% NaCl.
Click to Show/Hide
|
||||
Response regulation | The epithelial-mesenchymal transition (EMT) is an important pathological process in the occurrence of pulmonary fibrosis. SETDB1 regulates the expression of Snai1 by catalyzing the histone H3 lysine 9 trimethylation (H3K9me3) of Snai1, the main transcription factor that initiates the process of EMT, and thus, indirectly regulates E-cadherin (CDH1). And overexpressed SETDB1 alleviated EMT and also caused ferroptosis. | ||||
Pulmonary fibrosis [ICD-11: CB03]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | Histone-lysine N-methyltransferase SETDB1 (SETDB1) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell adhesion molecules | hsa04514 | ||||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
A-549 cells | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
In Vivo Model |
Forty Sprague-Dawley rats (weight 200 ± 20 g) were obtained from the Experimental Animal Center of Henan Province. The pulmonary fibrosis rat model was established using previously described techniques. The rats were administered a tracheal infusion of bleomycin at a concentration of 5 mg/kg in sterile 0.9% NaCl.
Click to Show/Hide
|
||||
Response regulation | The epithelial-mesenchymal transition (EMT) is an important pathological process in the occurrence of pulmonary fibrosis. SETDB1 regulates the expression of Snai1 by catalyzing the histone H3 lysine 9 trimethylation (H3K9me3) of Snai1, the main transcription factor that initiates the process of EMT, and thus, indirectly regulates E-cadherin (CDH1). And overexpressed SETDB1 alleviated EMT and also caused ferroptosis. | ||||